Results 141 to 150 of about 80,661 (193)

Probing the core metabolism of <i>Cereibacter sphaeroides</i> by transposon mutagenesis. [PDF]

J Bacteriol
Alber BE, Adair JA, Asao M, Bangudi S, Kotran SN, Sandman K.   +5 more
europepmc   +1 more source

Diagnostic challenge of high vitamin B12 levels: a case report and review of the literature. [PDF]

J Med Case Rep
Stella M, Sinico RA, Panvini FM, Manca A, Reggiani F, Calatroni M, Badalamenti S, Covini G.   +7 more
europepmc   +1 more source

Neuroprotective crosstalk from vitamin B12 and sphingolipid signaling pathways in therapy for multiple sclerosis. [PDF]

Int Immunol
Kihara Y, Chun J.
europepmc   +1 more source

Insights into Neutrophil Dysfunction in Inherited Metabolic Disorders. [PDF]

J Innate Immun
Wolf A, Montanelli G, Mathis D, Felser A, Laemmle A, Nuoffer JM, Gautschi M, Bourquin C, Stojkov D.   +8 more
europepmc   +1 more source

From silos to synergy: the interdisciplinary discovery potential in redefining polyendocrine metabolic ovarian syndrome. [PDF]

J Clin Invest
Morhaus MM, McLester-Davis LWY, Simcox JA.   +2 more
europepmc   +1 more source

Coated cobalamin alleviates heat stress in lactating Holstein cows by enhancing ruminal propionate production, antioxidant capacity, and hepatic mitogen-activated protein kinase signaling. [PDF]

J Anim Sci Biotechnol
Liu Y, Guo Z, Cao N, Diao Z, Ma L, Yang Y, Zhang Y, Bu D.   +7 more
europepmc   +1 more source

A carbon trail to follow: unveiling itaconate's metabolism in vivo. [PDF]

Immunometabolism (Cobham)
Anisov DE, Clayton SA, Nosenko MA.
europepmc   +1 more source

Advanced Ophthalmic Drug Delivery in Homocystinuria Type CblC: A Translational Review of Ophthalmic Pathologies and Therapeutic Opportunities. [PDF]

Pharmaceutics
Cuello-Rodríguez S, Sanna M, Lecoeuche I, Sarmento B, Otero-Espinar FJ, Díaz-Tomé V.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Treatment of a Methylmalonyl-CoA Mutase Stopcodon Mutation

Biochemical and Biophysical Research Communications, 2012
There are limited treatment options for the metabolic disorder methylmalonic aciduria. The disorder can be caused by nonsense mutations within the methylmalonyl-CoA mutase gene, resulting in the production of a truncated protein with little or no catalytic activity.
Leonie R Wood, Michael J Bennett
exaly   +3 more sources

A Radio-HPLC Assay for the Measurement of Methylmalonyl-CoA Mutase

Clinica Chimica Acta, 1984
Kim Bartlett, Anthony G Causey
exaly   +3 more sources